Suggestions appear as you type. Use the up and down arrows to choose one and Enter to open it.

This page's audience our own tag's counts — open to see them
–Visits
–Page views
–Clicks to vendors
–Time on page
–Reading now
Clicks to vendors, by tool
  • –
Top countries
  • –
Devices
  • –

– · visits, page views and clicks counted by our own tag, which counts more than our checked analytics; every figure rounded down · how we count

Standigm STELLA review

#23 of 30 in AI Drug Discovery Software

A focused cloud workspace for constrained candidate design and hit-to-lead optimization.

6.0/10Editor score
Standigm STELLA6.0 Try Standigm STELLA

Reviewed by iTechGuides Editors · Editorial team · Updated Oct 2026

Standigm STELLA is a cloud-based molecular design and hit-to-lead optimization workspace for drug-discovery teams, including medicinal chemists refining small-molecule candidates. It can generate compounds against selected pharmaceutical objectives, including activity and ADMET-related properties, while keeping a chosen scaffold. Teams can review candidate clusters and rankings, compare binding poses with a reference compound, and guide iterative design episodes with project data and feedback. The product is focused on molecule design rather than target identification or drug repurposing.

The published monthly plans show three fixed tiers: 1 token costs $2,500 per month, 2 tokens costs $4,500 per month, and 3 tokens costs $6,000 per month. Each includes scaffold-locked generation, automated binding-mode analysis, multi-parameter scoring, 3D pose visualization, a molecule library, and project history. A 14-day free trial is available without a credit card. The 4+ tokens tier lists unlimited parallel tasks, a dedicated account manager, custom integrations, an SLA, and enterprise security; its price is not stated here. This structure gives teams a way to expand token capacity, while the entry plan represents a substantial monthly commitment.

STELLA’s strongest fit is a workflow where candidate generation, docking analysis, property scoring, and medicinal-chemist review need to inform one another. Selected candidates can be exported to Excel, and the platform runs in the cloud through a web interface. For teams looking for target identification or repurposing, STELLA is not the relevant part of Standigm’s portfolio; those capabilities are described separately. Teams wanting a molecule-centered workflow for constrained hit-to-lead iteration may find the scope appropriate, while groups seeking a broader discovery platform should consider alternatives with those capabilities.

Standigm STELLA pros and cons

  • Where it wins
    • Generates candidates with scaffold constraints and multiple objectives
    • Combines docking, binding-mode analysis, scoring, and 3D pose views
    • Supports iterative design with user feedback and project history
  • Where it doesn't
    • Molecule-focused scope excludes target identification and drug repurposing
    • Monthly plans start at $2,500
    • Web-based cloud deployment may not fit teams requiring other deployment options

Standigm STELLA fact sheet, pricing and score →

Advertiser disclosure: iTechGuides is reader-supported. Vendors can pay for top positions in our rankings and for a place on other products' pages, and we may earn a commission when you click some links. Bought places stand at the number bought; this page and our disclosure say so. Paying vendors may get a fuller, more detailed review from our editors, and that review can change their score. How we rank.

Last updated · How we research and update